When did Praxis Precision Medicines, Inc. report Q4 2024 earnings?

Praxis Precision Medicines, Inc. (PRAX) reported Q4 2024 earnings on February 28, 2025 before market open.

What were Praxis Precision Medicines, Inc.'s Q4 2024 revenue and EPS?

Praxis Precision Medicines, Inc. reported revenue of $7.5M and eps of $-2.94 for Q4 2024.

Did Praxis Precision Medicines, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $297.9K by $7.2M. EPS missed the consensus estimate of $-2.76 by $0.18.

Where can I find Praxis Precision Medicines, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001689548-25-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.

Praxis Precision Medicines, Inc. PRAX Q4 2024 Annual earnings

Reported February 28, 2025 · Before market open

Revenue$7.5MBeat by $7.2M

EPS-$2.94Miss by $0.18

Revenue estimate$297.9K

EPS estimate-$2.76

Next report

Aug 10, 2026 (In 1 week)

Revenue estimate$1.3M

EPS estimate-$3.67

Financials

Q4 2024

Income statement

See full

Revenue$7.5M+1,349%

Operating income-$64.0M-130%

Net income-$58.7M-118%

EPS (diluted)-$3.00-53.1%

Balance sheet

See full

Cash & equivalents$215.8M+164%

Total debt$1.4M-45.1%

Total equity$445.5M+539%

Total assets$483.1M+449%

Cash flow

See full

Operating cash flow-$56.1M-135%

CapEx--100%

Free cash flow-$56.1M-135%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.43B+651%

Enterprise value$1.22B+992%

P/S167.7×+89.7×

Profitability

See full

Operating margin-2,340.3%-827pp

Net margin-2,137.5%-781pp

FCF margin-1,540.5%-613pp

Returns & leverage

See full

Return on equity-71%-26.1pp

Debt / equity0×0.0×

Current ratio10.8×+5.4×

Versus estimates

Revenue

Q4 2024$7.5MBeat by $7.2M

Diluted EPS

Q1 2026-$3.20Beat by $0.38 Q4 2025-$3.50Miss by $0.37 Q3 2025-$3.36Beat by $0.09 Q2 2025-$3.31Beat by $0.09 Q1 2025-$3.29Miss by $0.09

Q4 2024-$2.94Miss by $0.18

Ask the moment Praxis Precision Medicines, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Praxis Precision Medicines, Inc. report Q4 2024 earnings?: Praxis Precision Medicines, Inc. (PRAX) reported Q4 2024 earnings on February 28, 2025 before market open.
What were Praxis Precision Medicines, Inc.'s Q4 2024 revenue and EPS?: Praxis Precision Medicines, Inc. reported revenue of $7.5M and eps of $-2.94 for Q4 2024.
Did Praxis Precision Medicines, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $297.9K by $7.2M. EPS missed the consensus estimate of $-2.76 by $0.18.
Where can I find Praxis Precision Medicines, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001689548-25-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.